The biohacking stack: where peptides sit among NAD+, light, and cold
The biohacking stack has matured into a recognizable category. Peptide interest is one of its newer, more scrutinized entries.
Heredity Editorial · May 28, 2026 · 6 min
Biohacking has matured from forum curiosity into a recognizable commercial category, NAD+, red light, cold exposure, sleep tracking. Peptide interest is one of its newer and more scrutinized entries.
Not all inputs are equal
A cold plunge and a prescribed compound do not belong in the same risk tier, even if they share a wellness vocabulary. Lumping them together is how the riskiest items get the least scrutiny.
The supervised lane
Anything that touches prescription and the body's signalling belongs in a supervised lane, with a clinician and a licensed pharmacy, rather than in a self-assembled stack. That separation is the entire point of Heredity.
How Heredity approaches this
Heredity is application-only and clinically supervised. Membership is reviewed, not sold, and any protocol is designed and overseen by a licensed clinician, then compounded by a licensed U.S. pharmacy partner.
Nothing in this article is medical advice, nor a claim that any peptide diagnoses, treats, cures, or prevents any condition. Suitability is assessed individually. If a topic here is relevant to you, the right next step is a conversation, not a purchase.
Educational information only — not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any condition. Membership is reviewed individually; any protocol is overseen by a licensed clinician and dispensed by a licensed U.S. pharmacy partner. See our medical disclaimer.
